Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.
Ruff CT, Patel SM, Giugliano RP, Morrow DA, Hug B, Kuder JF, Goodrich EL, Chen SA, Goodman SG, Joung B, Kiss RG, Spinar J, Wojakowski W, Weitz JI, Murphy SA, Wiviott SD, Parkar S, Bloomfield D, Sabatine MS; AZALEA–TIMI 71 Investigators.
Ruff CT, et al.
N Engl J Med. 2025 Jan 23;392(4):361-371. doi: 10.1056/NEJMoa2406674.
N Engl J Med. 2025.
PMID: 39842011
Clinical Trial.